➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Merck
AstraZeneca
Mallinckrodt
Moodys
Medtronic

Last Updated: September 24, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02353676 Bupivacaine Supplementation For Postoperative Pain Control In Surgical Removal Of Mandibular Third Molars Not yet recruiting Cosmozone Dental Clinic N/A 2015-01-01 Control of postoperative pain is a foremost goal in achieving a satisfactory postoperative recovery. Surgical removal of lower third molars is accompanied by postoperative pain that is at its peak in the first 12 hours. Our study evaluates if the use of 2% lidocaine hydrochloride for the surgical removal of lower third molars with a postoperative 0.5% bupivacaine supplementation would result in lesser postoperative pain and a decrease in ingestion of oral analgesics to control the pain when compared to a placebo.
NCT03672500 Perineal Local Infiltration Study Suspended Sunnybrook Health Sciences Centre N/A 2018-09-14 The prevalence of birth canal lacerations is more than 70% of all deliveries in Canada. The repair of such lacerations is usually done using a pre-existing epidural analgesia. Once the analgesic effect of the epidural analgesia fades, the laceration may cause intolerable pain, and result in emotional stress, difficulties in ambulation and breastfeeding, and more. The research team hypothesis is that adding a locally injected analgesic, which will take effect once the epidural analgesia fades, may alleviate perineal pain, prevent such difficulties, and improve women's overall well-being and satisfaction. The proposed trial is a three-arm, single-masked, randomized trial. Women with a working epidural analgesia, and a laceration will be invited to participate. Women in the local anesthesia (LA) arm will get a LA injected to the laceration, women in the saline arm will get physiologic water injected to the laceration in order to mimic the swelling of the laceration without the anesthetic effects of the LA, and women in the sham arm will get no injection. The differences in perineal pain between the groups will be evaluated at 6 hours after last epidural dose.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE

Condition Name

Condition Name for BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
Intervention Trials
Anesthesia, Local 2
Episiotomy; Complications 1
Second Degree Perineal Tear During Delivery - Delivered 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
Intervention Trials
Pain, Postoperative 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE

Trials by Country

Trials by Country for BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
Location Trials
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE

Clinical Trial Phase

Clinical Trial Phase for BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
Clinical Trial Phase Trials
N/A 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
Clinical Trial Phase Trials
Not yet recruiting 1
Suspended 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE

Sponsor Name

Sponsor Name for BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
Sponsor Trials
Sunnybrook Health Sciences Centre 1
Cosmozone Dental Clinic 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
Sponsor Trials
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Mallinckrodt
Colorcon
McKesson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.